P01.08 Discovery of CRD1601, a potent and selective HPK1 inhibitor with robust in vivo anti-cancer activity

• S Basu,
• R Ghosh,
• D Yadav,
• M Banerjee,
• R Shrivastava,
• A Gautam,
• A Middya,
• N Mane,
• N Rawat,
• D Pryde,
• A Surya,
• S Middya,
• S Debnath,
• M Padaliya,
• S Bano

Affiliations

S Basu

Department of Pediatrics, NRS Medical College and Hospitals, Calcutta, West Bengal, India

R Ghosh

2Department of Neurosurgery, Thomas Jefferson University, Philadelphia, PA, USA

D Yadav

Paediatrics, PGIMER, Dr. RML Hospital, N Delhi, India

M Banerjee

2School of Medicine, University of Liverpool, Liverpool

R Shrivastava

Department of Internal Medicine, Park Ridge Hospital, Rochester, New York

A Gautam

1Curadev Pharma, Noida, India

A Middya

1Curadev Pharma, Noida, India

N Mane

1Curadev Pharma, Noida, India

N Rawat

1Curadev Pharma, Noida, India

D Pryde

2Curadev Pharma, Sandwich, UK

A Surya

1Curadev Pharma, Noida, India

S Middya

1Curadev Pharma Pvt Ltd, Noida, India

S Debnath

1Curadev Pharma Pvt Ltd, Noida, India

M Padaliya

1Curadev Pharma Pvt Ltd, Noida, India

S Bano

1Curadev Pharma Pvt Ltd, Noida, India